The latest closing stock price for Y-mAbs Therapeutics as of April 28, 2025 is 4.23.
An investor who bought $1,000 worth of Y-mAbs Therapeutics stock at the IPO in 2018 would have $-824 today, roughly -1 times their original investment - a -21.96% compound annual growth rate over 7 years.
The all-time high Y-mAbs Therapeutics stock closing price was 54.26 on December 17, 2020.
The Y-mAbs Therapeutics 52-week high stock price is 17.78, which is 320.3% above the current share price.
The Y-mAbs Therapeutics 52-week low stock price is 3.84, which is 9.2% below the current share price.
The average Y-mAbs Therapeutics stock price for the last 52 weeks is 10.28.
An investor who bought $1,000 worth of Y-mAbs Therapeutics stock at the IPO in 2018 would have $-824 today, roughly -1 times their original investment - a -21.96% compound annual growth rate over 7 years.
The all-time high Y-mAbs Therapeutics stock closing price was 54.26 on December 17, 2020.
The Y-mAbs Therapeutics 52-week high stock price is 17.78, which is 320.3% above the current share price.
The Y-mAbs Therapeutics 52-week low stock price is 3.84, which is 9.2% below the current share price.
The average Y-mAbs Therapeutics stock price for the last 52 weeks is 10.28.